Skip to main content
Livermore
Livermore
ZHEN

Raelipskie Partnership

SEC CIK
0002023896
Latest filing
Aug 4, 2026

The latest 13F from Raelipskie Partnership covers Q2 2026 (filed Aug 4, 2026): 124 long positions worth $264.8M. The top 10 holdings make up 60.7% of the portfolio, and the largest is SPDR S&P 500 ETF Trust (SPY) at 10.8%. Livermore has 11 filings on Form 13F from this institution, going back to Q4 2023.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
12
Est. +$1.09M
Added
30
Est. +$4.15M
Reduced
28
Est. −$7.25M
Sold out
7
Est. −$1.37M

Top 5 holdings

Share of this quarter's portfolio value

  1. SPYSPDR S&P 500 ETF Trust
    10.8%$28.7MHistory
  2. Vanguard Ftse Developed Markets ETF921943858
    8.8%$23.2M
  3. Invesco Exchange Traded FD T46137V357
    8.5%$22.5M
  4. Invesco QQQ Trust Series I46090E103
    8.4%$22.2M
  5. Vanguard Ftse Emerging Markets ETF922042858
    5.9%$15.5M

Share of portfolio

Top 5 holdings and the other 119 positions, by share of portfolio value

  1. SPY10.8%
  2. Vanguard Ftse Developed Markets ETF8.8%
  3. Invesco Exchange Traded FD T8.5%
  4. Invesco QQQ Trust Series I8.4%
  5. Vanguard Ftse Emerging Markets ETF5.9%
  6. Other 119 positions57.6%

Biggest buys

New and added positions, by estimated amount bought

  1. ACNAccenture plc
    +$1.05MNewHistory
  2. State Street SPDR Portfolio S&P 600 Small Cap ETF78468R853
    +$772.2KAdded
  3. PFEPfizer Inc
    +$608.1KAddedHistory
  4. MSFTMicrosoft Corp
    +$364.8KAddedHistory
  5. BRK.BBerkshire Hathaway Inc
    +$324.8KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MUMicron Technology Inc
    +1.06 pp0.5% → 1.6%History
  2. ACNAccenture plc
    +0.40 pp0.0% → 0.4%History
  3. State Street SPDR Portfolio S&P 600 Small Cap ETF78468R853
    +0.34 pp0.8% → 1.1%
  4. PFEPfizer Inc
    +0.20 pp0.1% → 0.3%History
  5. United Health Group Inc (USA)000696401
    +0.18 pp0.5% → 0.7%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CSCOCisco Systems, Inc.
    −$2.35MReducedHistory
  2. LYBLyondellBasell Industries N.V.
    −$1.17MSold outHistory
  3. iShares Russell 2000 ETF464287655
    −$1.13MReduced
  4. iShares Inc46434G764
    −$885.4KReduced
  5. Vanguard Ftse Developed Markets ETF921943858
    −$604.9KReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Exxon Mobil Corp (USA)000255969
    −0.55 pp1.9% → 1.3%
  2. LYBLyondellBasell Industries N.V.
    −0.50 pp0.5% → 0.0%History
  3. CSCOCisco Systems, Inc.
    −0.32 pp1.6% → 1.3%History
  4. Vanguard Ftse Developed Markets ETF921943858
    −0.30 pp9.1% → 8.8%
  5. Walmart Stores Inc (USA)000714160
    −0.25 pp1.3% → 1.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$264.8M
+$28.6M (+12.1%) vs. prior quarter
Positions
124
+5 vs. prior quarter
Top 10 concentration
60.7%
Top 10 as share of value
Turnover
2.1%
Q2 2026, one quarter
Average holding period
10.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2023), so positions held before then are understated.

13F filings by quarter

11 quarters, going back to Q4 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $264.8M (Q2 2026)

Q4 2023: $164.2MQ1 2024: $175.5MQ2 2024: $187.4MQ3 2024: $205.1MQ4 2024: $201.3MQ1 2025: $194.6MQ2 2025: $218.5MQ3 2025: $232.8MQ4 2025: $238.5MQ1 2026: $236.2MQ2 2026: $264.8M
Q4 2023Q2 2026
13F filings of Raelipskie Partnership by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 4, 2026124$264.8MSPYVanguard Ftse Developed Markets ETFInvesco Exchange Traded FD Tvs. Q1 2026SEC
Q1 2026Apr 29, 2026119$236.2MSPYVanguard Ftse Developed Markets ETFInvesco Exchange Traded FD Tvs. Q4 2025SEC
Q4 2025Feb 4, 2026117$238.5MSPYVanguard Ftse Developed Markets ETFInvesco Exchange Traded FD Tvs. Q3 2025SEC
Q3 2025Nov 4, 2025116$232.8MSPYVanguard Ftse Developed Markets ETFInvesco Exchange Traded FD Tvs. Q2 2025SEC
Q2 2025Aug 6, 2025117$218.5MSPYVanguard Ftse Developed Markets ETFInvesco Exchange Traded FD Tvs. Q1 2025SEC
Q1 2025May 15, 2025124$194.6MSPYVanguard Ftse Developed Markets ETFInvesco Exchange Traded FD Tvs. Q4 2024SEC
Q4 2024Jan 31, 2025121$201.3MSPYVanguard Ftse Developed Markets ETFInvesco QQQ Trust Series Ivs. Q3 2024SEC
Q3 2024Nov 15, 2024124$205.1MSPYVanguard Ftse Developed Markets ETFInvesco QQQ Trust Series Ivs. Q2 2024SEC
Q2 2024Jul 18, 2024101$187.4MSPYVanguard Ftse Developed Markets ETFInvesco QQQ Trust Series Ivs. Q1 2024SEC
Q1 2024May 23, 2024103$175.5MSPYVanguard Ftse Developed Markets ETFInvesco QQQ Trust Series Ivs. Q4 2023SEC
Q4 2023May 23, 202497$164.2MSPYVanguard Ftse Developed Markets ETFInvesco QQQ Trust Series I–SEC